NM_001038603.3:c.504A>G
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001038603.3(MARVELD2):c.504A>G(p.Thr168Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000303 in 1,614,068 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001038603.3 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000501 AC: 126AN: 251470Hom.: 0 AF XY: 0.000684 AC XY: 93AN XY: 135904
GnomAD4 exome AF: 0.000313 AC: 458AN: 1461844Hom.: 5 Cov.: 35 AF XY: 0.000459 AC XY: 334AN XY: 727208
GnomAD4 genome AF: 0.000204 AC: 31AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.000322 AC XY: 24AN XY: 74430
ClinVar
Submissions by phenotype
not specified Benign:1
p.Thr168Thr in exon 2 of MARVELD2: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wi thin the splice consensus sequence, and has been identified in 0.46% (76/16502) of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exa c.broadinstitute.org; dbSNP rs568560843). -
MARVELD2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at